Alejandro Arana, MD, MPH

Senior Director, Epidemiology

MD
School of Medicine, University of Zaragoza, Zaragoza, Spain
Specialist in Preventive Medicine and Public Health
University Hospital of Zaragoza and Department of Public Health, Government of Aragón, Zaragoza, Spain

MPH
Institute of Studies in Public Health, University of Valencia, Spain

MSc, Epidemiology
School of Medicine, Erasmus University, Rotterdam, The Netherlands

Alejandro Arana, MD, MPH, MSc, FISPE, is a Senior Director of Epidemiology at RTI-HS. Dr. Arana has 22 years of experience in research in pharmacoepidemiology. He has strong experience in regulatory observational studies using different data collection methods in multiple therapeutic areas, including automated health databases. He has authored numerous articles and publications in scientific journals. Particular areas of expertise are neurosciences and epidemiology methods. He also has expertise applying preventive medicine and public health methods to risk management, developing risk minimization strategies, and providing risk minimization assessment evaluation.

Dr. Arana has lectured at the London School of Hygiene & Tropical Medicine, UK; the Universidad de Barcelona, Spain; the Universidad de Zaragoza, Spain; and the Université Saint Antoine, Paris, France. He has participated in several multinational projects addressing epidemiologic and pharmacoepidemiologic issues, including the EURODEM and EURODEP (European Community Concerted Action on the Epidemiology and Prevention of Dementia or Depression Group), the UN-AIDS (United Nations Project on Acquired Immunodeficiency Syndrome), and the North American Registry of Epileptic Pregnancies.

Dr. Arana is a Fellow of the International Society for Pharmacoepidemiology (ISPE) and chair of the Spanish Chapter of ISPE (Farmaco EpiEnRed). From 2001 to 2011, he was member of the board of directors of the ISPE and cochair of the Industry Council of the Society. He currently chairs the methods working group of the European Network of Centers of Pharmacovigilance and Pharmacoepidemiology.